Influence of Early versus Late supplemental ParenteraL Nutrition on long-term quality of life in ICU patients after gastrointestinal oncological surgery (hELPLiNe): study protocol for a randomized controlled trial

Paweł Piwowarczyk, Paweł Kutnik, Michał Borys, Elżbieta Rypulak, Beata Potręć-Studzińska, Justyna Sysiak-Sławecka, Tomasz Czarnik, Mirosław Czuczwar, Paweł Piwowarczyk, Paweł Kutnik, Michał Borys, Elżbieta Rypulak, Beata Potręć-Studzińska, Justyna Sysiak-Sławecka, Tomasz Czarnik, Mirosław Czuczwar

Abstract

Background: Nutrition plays a major role in intensive care unit (ICU) treatment, influencing ICU length of stay and patient's survival. If preferable enteral nutrition administration is not feasible, ESPEN and ASPEN guidelines recommend initiation of a supplemental parenteral route between the first and seventh day, but exact timing remains elusive. While rapid development in critical care enabled significant reduction in the mortality rate of ICU patients, this improvement also tripled the number of patients going to rehabilitation. Thus, it is quality of life after ICU that has become the subject of interest of clinicians and healthcare policy-makers. A growing body of evidence indicates that protein turnover in the early phase of critical illness may play a crucial role in the preservation of lean body mass. A negative protein balance may lead to muscle wasting that persists weeks and months after ICU stay, resulting in deterioration of physical functioning. Folliwing oncological gastrointestinal tract surgery, patients are threatened with negative protein turnover due to cancer and extensive surgical insult.

Methods: This is a multi-centre, single-blinded, randomised controlled trial. The study population includes patients admitted to ICU units after major oncological gastrointestinal surgery that require supplemental parenteral nutrition. After initiation of enteral nutrition, the intervention group receives remaining daily requirement via supplemental parenteral nutrition on the first day of ICU stay while the control group is not supplemented parenterally until the seventh day of ICU stay while enteral nutrition is gradually increased. Primary endpoint: long-term quality of life measured in the physical component score (PCS) of SF-36 questionnaire at 3 and 6 months after ICU admission.

Discussion: To our knowledge, this is the first trial to investigate the influence of early supplemental parenteral nutrition on long-term quality of life after major oncological gastrointestinal surgery. We assume that, particularly in this population of patients, early supplemental parenteral nutrition may increase the long-term quality of life. The study construction also allows establishment of patients' PCS SF-36 score prior to surgery and mean change in PCS SF-36 score during the recovery period, which is rarely seen in studies on critically ill patients.

Trial registration: ClinicalTrials.gov: NCT03699371 registered on 12 October 2018.

Keywords: ICU; Supplemental parenteral nutrition; cancer; gastrointestinal surgery; protein; quality of life.

Conflict of interest statement

MCz declares a competing interest by receiving honoraria for lectures and advisory groups on nutrition from the following pharmaceutical companies: Fresenius Medical Care, Fresenius Kabi, Nutricia, BBraun, Baxter, Nestle. Other authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Chart flow
Fig. 2
Fig. 2
Study period

References

    1. Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38:48–79. doi: 10.1016/j.clnu.2018.08.037.
    1. Wischmeyer PE. Are we creating survivors … or victims in critical care? Delivering targeted nutrition to improve outcomes. Curr Opin Crit Care. 2016;22(4):279–284. doi: 10.1097/MCC.0000000000000332.
    1. Wischmeyer PE, San-Millan I. Winning the war against ICU-acquired weakness: new innovations in nutrition and exercise physiology. Crit Care. 2015;19(Suppl 3):S6. doi: 10.1186/cc14724.
    1. Demling RH. Nutrition, anabolism, and the wound healing process: an overview. Eplasty. 2009;9:e9.
    1. Wernerman J, Hammarqvist F, Gamrin L, Essén P. Protein metabolism in critical illness. Bailliere Clin Endocrinol Metab. 1996;10:603–615. doi: 10.1016/S0950-351X(96)80756-7.
    1. Sundström Rehal M, Liebau F, Tjäder I, et al. A supplemental intravenous amino acid infusion sustains a positive protein balance for 24 hours in critically ill patients. Crit Care. 2017;21(1):298. doi: 10.1186/s13054-017-1892-x.
    1. Katsanos CS, Chinkes DL, Paddon-Jones D, Zhang XJ, Aarsland A, Wolfe RR. Whey protein ingestion in elderly persons results in greater muscle protein accrual than ingestion of its constituent essential amino acid content. Nutr Res. 2008;28:651–658. doi: 10.1016/j.nutres.2008.06.007.
    1. Moore DR, Robinson MJ, Fry JL, Tang JE, Glover EI, Wilkinson SB, Prior T, Tarnopolsky MA, Phillips SM. Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. Am J Clin Nutr. 2009;89:161–168. doi: 10.3945/ajcn.2008.26401.
    1. Allingstrup MJ, Kondrup J, Wiis J, et al. Early goal-directed nutrition versus standard of care in adult intensive care patients: the single-centre, randomised, outcome assessor-blinded EAT-ICU trial. Intensive Care Med. 2017;43(11):1637–1647. doi: 10.1007/s00134-017-4880-3.
    1. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311:1308–1316. doi: 10.1001/jama.2014.2637.

Source: PubMed

3
Subscribe